Sino Biopharmaceutical Limited (HKG:1177)

Sino Biopharmaceutical Statistics

Total Valuation

HKG:1177 has a market cap or net worth of HKD 161.14 billion. The enterprise value is 166.11 billion.

Market Cap	161.14B
Enterprise Value	166.11B

Important Dates

The last earnings date was Monday, August 25, 2025.

Earnings Date	Aug 25, 2025
Ex-Dividend Date	Aug 29, 2025

Share Statistics

HKG:1177 has 17.88 billion shares outstanding. The number of shares has decreased by -2.10% in one year.

Current Share Class	17.88B
Shares Outstanding	17.88B
Shares Change (YoY)	-2.10%
Shares Change (QoQ)	-0.85%
Owned by Insiders (%)	50.76%
Owned by Institutions (%)	17.43%
Float	8.81B

Valuation Ratios

The trailing PE ratio is 38.19 and the forward PE ratio is 33.61. HKG:1177's PEG ratio is 1.28.

PE Ratio	38.19
Forward PE	33.61
PS Ratio	4.81
PB Ratio	3.21
P/TBV Ratio	4.86
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	1.28

Enterprise Valuation

EV / Earnings	39.16
EV / Sales	4.96
EV / EBITDA	22.08
EV / EBIT	26.55
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.36, with a Debt / Equity ratio of 0.26.

Current Ratio	1.36
Quick Ratio	1.14
Debt / Equity	0.26
Debt / EBITDA	1.73
Debt / FCF	n/a
Interest Coverage	21.69

Financial Efficiency

Return on equity (ROE) is 15.40% and return on invested capital (ROIC) is 6.55%.

Return on Equity (ROE)	15.40%
Return on Assets (ROA)	5.07%
Return on Invested Capital (ROIC)	6.55%
Return on Capital Employed (ROCE)	11.47%
Revenue Per Employee	1.45M
Profits Per Employee	183,989
Employee Count	24,379
Asset Turnover	0.43
Inventory Turnover	2.83

Taxes

In the past 12 months, HKG:1177 has paid 942.53 million in taxes.

Income Tax	942.53M
Effective Tax Rate	11.27%

Stock Price Statistics

The stock price has increased by +184.23% in the last 52 weeks. The beta is 0.71, so HKG:1177's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	+184.23%
50-Day Moving Average	7.20
200-Day Moving Average	4.53
Relative Strength Index (RSI)	68.65
Average Volume (20 Days)	159,906,760

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1177 had revenue of HKD 33.49 billion and earned 4.24 billion in profits. Earnings per share was 0.23.

Revenue	33.49B
Gross Profit	27.39B
Operating Income	6.29B
Pretax Income	8.36B
Net Income	4.24B
EBITDA	7.56B
EBIT	6.29B
Earnings Per Share (EPS)	0.23

Balance Sheet

The company has 21.72 billion in cash and 13.10 billion in debt, giving a net cash position of 8.62 billion or 0.48 per share.

Cash & Cash Equivalents	21.72B
Total Debt	13.10B
Net Cash	8.62B
Net Cash Per Share	0.48
Equity (Book Value)	50.16B
Book Value Per Share	2.03
Working Capital	9.83B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 81.77%, with operating and profit margins of 18.78% and 12.67%.

Gross Margin	81.77%
Operating Margin	18.78%
Pretax Margin	24.96%
Profit Margin	12.67%
EBITDA Margin	22.56%
EBIT Margin	18.78%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 1.12%.

Dividend Per Share	0.10
Dividend Yield	1.12%
Dividend Growth (YoY)	50.00%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.10%
Shareholder Yield	3.22%
Earnings Yield	2.63%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 20, 2020. It was a forward split with a ratio of 1.5.

Last Split Date	Jul 20, 2020
Split Type	Forward
Split Ratio	1.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	5